$SKIN
Beauty Health Co Stock $skin

$skin Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000162828024036238 Filed on August 08, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q4
Revenue	$78.80M	$90.59M	$96.82M
YoY Change	-19.11%	-22.88%	-1.34%
Cost Of Revenue	$38.15M	$49.65M	$13.24M
YoY Change	-65.3%	0.1%	-59.84%
Gross Profit	$40.65M	$40.94M	$83.59M
YoY Change	-423.82%	-39.68%	28.25%
Gross Profit Margin	51.58%	45.19%	86.33%
Selling, General & Admin	$61.06M	$61.89M	$61.00M
YoY Change	-9.83%	-20.79%	-6.05%
% of Gross Profit	150.2%	151.18%	72.98%
Research & Development	$1.108M	$1.159M	$3.046M
YoY Change	-39.75%	-59.77%	110.65%
% of Gross Profit	2.73%	2.83%	3.64%
Depreciation & Amortization	$8.114M	$7.928M	$9.288M
YoY Change	10.39%	-19.93%	-9.34%
% of Gross Profit	19.96%	19.36%	11.11%
Operating Expenses	$62.16M	$63.05M	$64.05M
YoY Change	-10.62%	-22.18%	-7.1%
Operating Profit	-$21.52M	-$22.11M	$19.54M
YoY Change	-73.79%	68.2%	-618.99%
Interest Expense	$4.685M	$598.0K	$6.142M
YoY Change	35.99%	-77.73%	39.09%
% of Operating Profit			31.43%
Other Income/Expense, Net	$69.00K	$17.32M	$3.418M
YoY Change	-98.58%	48.89%	76.0%
Pretax Income	-$16.34M	-$151.0K	-$8.800M
YoY Change	-76.77%	-112.89%	-439.38%
Income Tax	$1.948M	-$353.0K	$603.0K
% Of Pretax Income
Net Earnings	-$18.29M	$202.0K	-$9.403M
YoY Change	-75.22%	-94.0%	-346.47%
Net Earnings / Revenue	-23.21%	0.22%	-9.71%
Basic Earnings Per Share	-$0.15	$0.00
Diluted Earnings Per Share	-$0.15	-$0.10	-$0.07
COMMON SHARES
Basic Shares Outstanding	124.0M shares	123.6M shares	131.3M shares
Diluted Shares Outstanding	124.1M shares	141.9M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$358.9M	$349.5M	$523.0M
YoY Change	-35.84%	-36.42%	-7.95%
Cash & Equivalents	$358.9M	$349.5M	$523.0M
Short-Term Investments
Other Short-Term Assets	$16.03M	$21.13M	$28.88M
YoY Change	-55.34%	-31.71%	8.16%
Inventory	$73.44M	$77.14M	$91.32M
Prepaid Expenses
Receivables	$36.28M	$41.41M	$54.70M
Other Receivables	$399.0K	$401.0K	$332.0K
Total Short-Term Assets	$485.0M	$489.6M	$698.3M
YoY Change	-34.28%	-36.24%	-11.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$22.23M	$24.66M	$26.35M
YoY Change	-24.38%	-22.33%	-22.1%
Goodwill	$125.5M	$124.8M	$125.8M
YoY Change	0.62%	-0.42%	0.98%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$14.66M	$15.53M	$16.04M
YoY Change	-5.64%	-7.92%	13.03%
Total Long-Term Assets	$214.5M	$222.2M	$230.9M
YoY Change	-8.75%	-7.23%	5.03%
TOTAL ASSETS
Total Short-Term Assets	$485.0M	$489.6M	$698.3M
Total Long-Term Assets	$214.5M	$222.2M	$230.9M
Total Assets	$699.5M	$711.8M	$929.1M
YoY Change	-28.11%	-29.34%	-7.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$23.08M	$26.69M	$44.77M
YoY Change	-35.67%	-9.17%	47.58%
Accrued Expenses	$28.09M	$24.04M	$19.85M
YoY Change	-7.86%	-52.1%	30.71%
Deferred Revenue	$3.263M	$3.875M	$450.0K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$73.95M	$75.43M	$115.0M
YoY Change	-41.25%	-8.89%	57.3%
LONG-TERM LIABILITIES
Long-Term Debt	$551.4M	$550.6M	$738.4M
YoY Change	-25.21%	-25.21%	0.58%
Other Long-Term Liabilities	$699.0K	$1.849M	$2.767M
YoY Change	70.49%	-92.47%	-90.17%
Total Long-Term Liabilities	$699.0K	$1.849M	$2.767M
YoY Change	70.49%	-99.76%	-99.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$73.95M	$75.43M	$115.0M
Total Long-Term Liabilities	$699.0K	$1.849M	$2.767M
Total Liabilities	$639.8M	$642.6M	$869.7M
YoY Change	-27.55%	-24.0%	3.86%
SHAREHOLDERS EQUITY
Retained Earnings	-$497.6M	-$479.3M	-$478.9M
YoY Change	6.0%	21.15%	27.93%
Common Stock	$12.00K	$12.00K	$12.00K
YoY Change	-14.29%	-14.29%	-14.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$59.72M	$69.19M	$59.39M
YoY Change
Total Liabilities & Shareholders Equity	$699.5M	$711.8M	$929.1M
YoY Change	-28.11%	-29.34%	-7.91%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q4
OPERATING ACTIVITIES
Net Income	-$18.29M	$202.0K	-$9.403M
YoY Change	-75.22%	-94.0%	-346.47%
Depreciation, Depletion And Amortization	$8.114M	$7.928M	$9.288M
YoY Change	10.39%	-19.93%	-9.34%
Cash From Operating Activities	$10.32M	$6.201M	-$5.170M
YoY Change	-42.57%	-71.77%	-4.13%
INVESTING ACTIVITIES
Capital Expenditures	$2.092M	$2.038M	$2.168M
YoY Change	-27.61%	-36.69%	-23.23%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$2.000K
YoY Change	-100.0%
Cash From Investing Activities	-$2.092M	-$2.038M	-$2.168M
YoY Change	-52.88%	-36.69%	-23.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-204.0K	-98.75M	-31.36M
YoY Change	-91.32%	6287.39%	-69.4%
NET CHANGE
Cash From Operating Activities	10.32M	6.201M	-5.170M
Cash From Investing Activities	-2.092M	-2.038M	-2.168M
Cash From Financing Activities	-204.0K	-98.75M	-31.36M
Net Change In Cash	8.019M	-94.59M	-38.70M
YoY Change	-28.21%	-649.89%	-65.04%
FREE CASH FLOW
Cash From Operating Activities	$10.32M	$6.201M	-$5.170M
Capital Expenditures	$2.092M	$2.038M	$2.168M
Free Cash Flow	$8.223M	$4.163M	-$7.338M
YoY Change	-45.43%	-77.79%	-10.7%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	123993785	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	123993785	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	122899002	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	122899002	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	59390000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-679000	usd
CY2024Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1005000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6636000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1047000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	63295000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	202000	usd
CY2024Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	368000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	378000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-477000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	13134000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	12101000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10255000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11126000	usd
	us-gaap	Depreciation Depreciation	4483000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	19304000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2037000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1380000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2579000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2509000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	33411000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2144000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	7515000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	1796000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-10499000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	138000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6572000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2605000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-6264000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	12188000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-38686000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	9239000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	4848000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	4420000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10653000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8956000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3162000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4365000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	678000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3623000	usd
	skin	Payments For Asset Acquisitions PaymentsForAssetAcquisitions	0	usd
	skin	Payments For Asset Acquisitions PaymentsForAssetAcquisitions	16915000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3840000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24903000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	156082000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1285000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2083000	usd
	skin	Payment Of Accelerated Share Repurchases PaymentOfAcceleratedShareRepurchases	0	usd
	skin	Payment Of Accelerated Share Repurchases PaymentOfAcceleratedShareRepurchases	2240000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	582000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-157367000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3741000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-171860000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-19688000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1621000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1219000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	523025000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	568197000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	349544000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	549728000	usd
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	90594000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	117479000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	171997000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	203757000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	90594000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	117479000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	171997000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	203757000	usd
CY2024Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	23907000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	24406000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	53236000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	66915000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	77143000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	91321000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	19300000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	4400000	usd
CY2024Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	9323000	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	10458000	usd
CY2024Q2	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	5492000	usd
CY2023Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	7565000	usd
CY2024Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	2331000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	4005000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17146000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	22028000	usd
CY2024Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	4798000	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	4971000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3875000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	450000	usd
CY2024Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	3769000	usd
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	3914000	usd
CY2024Q2	us-gaap	Interest Payable Current InterestPayableCurrent	1719000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2344000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	9883000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	8167000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	24044000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19846000	usd
CY2024Q2	us-gaap	Nontrade Receivables NontradeReceivables	9000000	usd
CY2023Q4	us-gaap	Nontrade Receivables NontradeReceivables	15000000	usd
CY2024Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	7000000	usd
CY2024Q2	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	2000000	usd
CY2024Q2	us-gaap	Restricted Cash RestrictedCash	2000000	usd
CY2024Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	24299000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	19953000	usd
CY2024Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	9718000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	14226000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	125818000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-996000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	124822000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	151360000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	97199000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	54161000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	149392000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	87269000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	62123000	usd
CY2024Q2	us-gaap	Debt Instrument Repurchased Face Amount DebtInstrumentRepurchasedFaceAmount	192300000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	156100000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	33400000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2200000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5900000	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1400000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1100000	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6498000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8524000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13134000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12101000	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	44800000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y10M24D
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	320000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	skin	Common Stock Voting Rights Votes CommonStockVotingRightsVotes	1	vote
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	123993785	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	123993785	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	122899002	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	122899002	shares
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	202000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3364000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-477000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-16895000	usd
CY2024Q2	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	-14651000	usd
CY2023Q2	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	usd
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	-27722000	usd
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-14449000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3364000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-28199000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-16895000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	123718797	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	132716024	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	123417353	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	132569209	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	18208953	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	19782868	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	141927750	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	132716024	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	143200221	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	132569209	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2023Q4	skin	Syndeo Program Reserves SyndeoProgramReserves	21009000	usd
CY2024Q1	skin	Syndeo Program Usage SyndeoProgramUsage	12695000	usd
CY2024Q1	skin	Syndeo Program Reserves SyndeoProgramReserves	8314000	usd
CY2024Q2	skin	Syndeo Program Usage SyndeoProgramUsage	7402000	usd
CY2024Q2	skin	Syndeo Program Reserves SyndeoProgramReserves	912000	usd
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-036238-index-headers.html	Edgar Link	pending
0001628280-24-036238-index.html	Edgar Link	pending
0001628280-24-036238.txt	Edgar Link	pending
0001628280-24-036238-xbrl.zip	Edgar Link	pending
ex311-2024q210q.htm	Edgar Link	pending
ex312-2024q210q.htm	Edgar Link	pending
ex321-2024q210q.htm	Edgar Link	pending
ex322-2024q210q.htm	Edgar Link	pending
exhibit105-bhc_mikemonah.htm	Edgar Link	pending
exhibit105-bhc_mikemonah001.jpg	Edgar Link	pending
exhibit105-bhc_mikemonah002.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
skin-20240630.htm	Edgar Link	pending
skin-20240630.xsd	Edgar Link	pending
skin-20240630_cal.xml	Edgar Link	unprocessable
skin-20240630_def.xml	Edgar Link	unprocessable
skin-20240630_lab.xml	Edgar Link	unprocessable
skin-20240630_pre.xml	Edgar Link	unprocessable
skin-20240630_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SKIN
Beauty Health Co Stock $skin

2024 Q3 Form 10-Q Financial Statement

#000162828024036238 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SKIN Beauty Health Co Stock $skin

2024 Q3 Form 10-Q Financial Statement

#000162828024036238 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SKIN
Beauty Health Co Stock $skin